Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2787 of 5804
-
Fish oil may shield cancer patients from chemo nerve pain
Prevention Recruiting nowThe purpose of this study is to examine the effect of supplementary polyunsaturated fatty acids on nerve damage in the body's extremitites of patients treated with oxaliplatin containing chemotherapy after surgery for colorectal cancer.
Phase: NA • Sponsor: Vejle Hospital • Aim: Prevention
Last updated Jun 27, 2026 12:35 UTC
-
Fish oil for autism: new study tests if Omega-3s calm behavior
Symptom relief Recruiting nowThis is a 12 week study to investigate the effects of omega-3 polyunsaturated fatty acids (PUFAs) in youth with autism spectrum disorder (ASD).
Phase: NA • Sponsor: China Medical University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:14 UTC
-
Writing away the pain: new study tests expressive helping for cancer survivors
Symptom relief OngoingThe Chinese American Cancer Survivors Writing Study is a Randomized Controlled Trial (RCT) testing the feasibility and efficacy of the Expressive Helping (EH) intervention among Chinese American cancer survivors.
Phase: NA • Sponsor: New York University • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
New drug shows promise in reducing lung scarring in small trial
Disease control CompletedThis is a Phase 2a, single -center, randomized, double-blind, placebo-controlled study to evaluate type 1 collagen deposition in the lungs following once-daily treatment with PLN-74809 for 12-weeks. This study is occurring at Massachusetts General Hospital.
Phase: PHASE2 • Sponsor: Pliant Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Light therapy app aims to ease dry mouth for cancer survivors
Symptom relief Recruiting nowThe Photobiomodulation therapy could have positive effects on quality of life and oral health in head and neck cancer survivors post-radiotherapy. The improvement in quality of life will be maintained after a follow-up period.
Phase: NA • Sponsor: Universidad de Granada • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Brain study seeks to unravel loneliness in mental illness
Knowledge-focused Recruiting nowThe proposed research will test the hypothesis that objective social isolation and loneliness are linked to neurobehavioral mechanisms involved in social perception and motivation in individuals with and without serious mental illness. Moreover, it will investigate the specific d…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC
-
Virtual reality could help measure and treat cancer pain, study suggests
Knowledge-focused TerminatedThis study aims to develop objective tools for assessing perceived pain severity in cancer patients and survivors, evaluate the sustained effectiveness of non-pharmacological interventions such as virtual reality in reducing pain and medication use, and create tools for the early…
Phase: NA • Sponsor: Roswell Park Cancer Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Could a common blood thinner help fight ovarian cancer?
Disease control Recruiting nowBackground: Previous findings have indicated antineoplastic properties of tinzaparin (Innohep®), a commonly used anti-coagulant. Earlier studies have mainly investigated the antineoplastic effects of tinzaparin in animal models and in human cell-lines. In this pilot study the ai…
Phase: PHASE2 • Sponsor: University Hospital, Linkoeping • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New PET tracer could spot deadly lung disease years earlier
Diagnosis Recruiting nowPulmonary arterial hypertension (PAH) is mortal disease affecting the blood vessels of the lung. Despite its morbid prognosis, PAH is often misdiagnosed or ignored, with an average time of 44 months between onset of symptoms to diagnosis and substantial progression of disease sev…
Phase: EARLY_PHASE1 • Sponsor: Stephen Y. Chan • Aim: Diagnosis
Last updated Jun 27, 2026 08:13 UTC
-
Pompe disease patients get continued enzyme therapy in Long-Term safety study
Disease control OngoingThis long-term open label safety and efficacy study is intended to follow up, and to provide post-trial access to enzyme replacement therapy (ERT) with avalglucosidase alfa to patients with Pompe disease in France who have completed Study EFC14028, LTS13769, or ACT14132, from mar…
Phase: PHASE4 • Sponsor: Genzyme, a Sanofi Company • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Experimental pill aims to rev up immune system against Hard-to-Treat tumors
Disease control Recruiting nowRBS2418 (investigational product) is a specific immune modulator, working through ectonucleotide pyrophosphatase/phosphodiesterase I (ENPP1), designed to lead to anti-tumor immunity by increasing endogenous 2'-3'-cyclic guanosine monophosphate-adenosine monophosphate (cGAMP) and …
Phase: PHASE1 • Sponsor: Riboscience, LLC. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New drug PEEL-224 enters first human tests for advanced cancers
Disease control Recruiting nowThis is a first-in-human, dose escalation, repeat-dose, multi-center, open-label study evaluating safety, tolerability, PK, and preliminary antitumor activity of PEEL-224 in patients with advanced solid tumors.
Phase: PHASE1 • Sponsor: Peel Therapeutics Inc • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Mindfulness machine: new device may ease anxiety without pills
Symptom relief CompletedThis randomized controlled trial compared the effectiveness of a 10-day mindfulness training program using adaptive biofeedback (BFB) versus medication therapy (escitalopram 10 mg/day) versus combined treatment (BFB + medication) in inpatients with anxiety disorders (ICD-10 F40/F…
Phase: PHASE4 • Sponsor: I.M. Sechenov First Moscow State Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Can a painkiller cream stop burn scars?
Disease control CompletedBurn patients very commonly develop abnormal scars after injury which can be red, raised or elevated, painful and very itchy. They can prevent normal movement of hands and other joints and lead to ugly deformities which makes physical and psychological recovery very difficult. Th…
Phase: PHASE2 • Sponsor: University of Alberta • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Art therapy boosts bonds for moms and kids with intellectual disabilities
Symptom relief CompletedThe caregiving of children with intellectual disability (ID) is intensive and challenging. Caregivers, particularly mothers, are left in a vulnerable and stressful condition. Children with ID may experience difficulties in expressing emotions and may have behavioral or emotional …
Phase: NA • Sponsor: The University of Hong Kong • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
Experimental cell therapy targets Hard-to-Treat sarcoma
Disease control TerminatedThe main purpose of this trial is to evaluate the efficacy and safety of TAEST16001 cells in the treatment of advanced soft tissue sarcoma patients with HLA-A\*02:01 tissue genotype and positive tumor antigen NY-ESO-1 expression.
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
Timing your meals may lower breast cancer risk, study finds
Prevention CompletedThis study will evaluate the implementation and effectiveness of free-living TRE on biological and behavioural breast cancer risk factors.
Phase: NA • Sponsor: University of Toronto • Aim: Prevention
Last updated Jun 27, 2026 07:53 UTC
-
Could your own nerves help heal Parkinson's? small trial begins
Disease control OngoingThis is an open-label, non-randomized, single-arm trial design to actively follow participants for 12 months. Ten participants will be enrolled to receive bilateral delivery of Peripheral Nerve Tissue (PNT) to the Substantia Nigra at the time of Deep Brain Stimulation (DBS) surge…
Phase: PHASE1 • Sponsor: Craig van Horne, MD, PhD • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Heart surgery patients get faster healing with own blood plasma
Disease control CompletedThe goal of this clinical trial is to learn whether applying autologous platelet-rich plasma (PRP) to the sternal wound during heart surgery improves wound healing and reduces complications after surgery. The study also aims to evaluate whether PRP can reduce hospital-related out…
Phase: NA • Sponsor: Shaheed Zulfiqar Ali Bhutto Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Breast cancer drug ribociclib made available Long-Term in new study
Disease control OngoingThe purpose of this study is to assess the long-term safety of ribociclib (LEE011) in combination with other drugs and provide post-trial access (PTA) to participants who are currently receiving treatment with ribociclib in combination with other drugs and continuing to have clin…
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC